Authors:
Wolfers, J
Lozier, A
Raposo, G
Regnault, A
Thery, C
Masurier, C
Flament, C
Pouzieux, S
Faure, F
Tursz, T
Angevin, E
Amigorena, S
Zitvogel, L
Citation: J. Wolfers et al., Tumor-derived exosomes are a source of shared tumor rejection antigens forCTL cross-priming, NAT MED, 7(3), 2001, pp. 297-303
Authors:
Valteau-Couanet, D
Angevin, E
Leboulaire, C
Beaussier, PS
Bayle, C
Hartmann, O
Beaujean, F
Citation: D. Valteau-couanet et al., In vitro generation of cytotoxic effecters activated by interleukin 2 (IL-2): comparison of autologous peripheral blood stem cells (PBSC) from adultsand children, BONE MAR TR, 27(8), 2001, pp. 869-875
Authors:
Glukhova, L
Angevin, E
Lavialle, C
Cadot, B
Terrier-Lacombe, MJ
Perbal, B
Bernheim, A
Goguel, AF
Citation: L. Glukhova et al., Patterns of specific genomic alterations associated with poor prognosis inhigh-grade renal cell carcinomas, CANC GENET, 130(2), 2001, pp. 105-110
Authors:
Bernard, J
Treton, D
Vermot-Desroches, C
Boden, C
Horellou, P
Angevin, E
Galanaud, P
Wijdenes, J
Richard, Y
Citation: J. Bernard et al., Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13R alpha 2 as a decoy receptor for IL13, LAB INV, 81(9), 2001, pp. 1223-1231
Authors:
Motta, I
Andre, F
Lim, A
Tartaglia, J
Cox, WI
Zitvogel, L
Angevin, E
Kourilsky, P
Citation: I. Motta et al., Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells, J IMMUNOL, 167(3), 2001, pp. 1795-1802
Authors:
Ikarashi, Y
Mikami, R
Bendelac, A
Terme, M
Chaput, N
Terada, M
Tursz, T
Angevin, E
Lemonnier, FA
Wakasugi, H
Zitovogel, L
Citation: Y. Ikarashi et al., Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: Critical role for B7 in CD1d-dependent NKT cell interferon gamma production, J EXP MED, 194(8), 2001, pp. 1179-1186
Authors:
Scardino, A
Alves, P
Gross, DA
Tourdot, S
Graff-Dubois, S
Angevin, E
Firat, H
Chouaib, S
Lemonier, F
Nadler, LM
Cardoso, AA
Kosmatopoulos, K
Citation: A. Scardino et al., Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors, EUR J IMMUN, 31(11), 2001, pp. 3261-3270
Authors:
Gati, A
Guerra, N
Giron-Michel, J
Azzarone, B
Angevin, E
Moretta, A
Chouaib, S
Caignard, A
Citation: A. Gati et al., Tumor cells regulate the lytic activity of tumor-specific cytotoxic T lymphocytes by modulating the inhibitory natural killer receptor function, CANCER RES, 61(8), 2001, pp. 3240-3244
Authors:
Ibrahim, EC
Guerra, N
Lacombe, MJT
Angevin, E
Chouaib, S
Carosella, ED
Caignard, A
Paul, P
Citation: Ec. Ibrahim et al., Tumor-specific up-regulation of the nonclassical class IHLA-G antigen expression in renal carcinoma, CANCER RES, 61(18), 2001, pp. 6838-6845
Authors:
Chouaib, S
Echchakir, H
Angevin, E
Guerra, N
Kosmatopoulos, K
Caignard, A
Lim, A
Baron, V
Ferradini, L
Mami-Chouaib, F
Citation: S. Chouaib et al., Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring, B CANCER, 88(8), 2001, pp. 733-740
Authors:
Merad, M
Angevin, E
Wolfers, T
Flament, C
Lorenzi, I
Triebel, F
Escudier, B
Zitvogel, L
Citation: M. Merad et al., Generation of monocyte-derived dendritic cells from patients with renal cell cancer: Modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12), J IMMUNOTH, 23(3), 2000, pp. 369-378
Authors:
Glukhova, L
Lavialle, C
Fauvet, D
Chudoba, I
Danglot, G
Angevin, E
Bernheim, A
Goguel, AF
Citation: L. Glukhova et al., Mapping of the 7q31 subregion common to the small chromosome 7 derivativesfrom two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene, ONCOGENE, 19(6), 2000, pp. 754-761
Authors:
Guerra, N
Guillard, M
Angevin, E
Echchakir, H
Escudier, B
Moretta, A
Chouaib, S
Caignard, A
Citation: N. Guerra et al., Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas, BLOOD, 95(9), 2000, pp. 2883-2889
Authors:
Le Cesne, A
Vassal, G
Farace, F
Spielmann, M
Le Chevalier, T
Angevin, E
Valteau-Couanet, D
Fizazi, K
Cojean, I
Llombard, A
Tursz, T
Escudier, B
Citation: A. Le Cesne et al., Combination interleukin-2 and doxorubicin in advanced adult solid tumors: Circumvention of doxorubicin resistance in soft-tissue sarcoma?, J IMMUNOTH, 22(3), 1999, pp. 268-277
Authors:
Durrbach, A
Angevin, E
Poncet, P
Rouleau, M
Chavanel, G
Chapel, A
Thierry, D
Gorter, A
Hirsch, R
Charpentier, B
Senik, A
Hirsch, F
Citation: A. Durrbach et al., Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro, CANC GENE T, 6(6), 1999, pp. 564-571
Authors:
Angevin, E
Glukhova, L
Pavon, C
Chassevent, A
Terrier-Lacombe, MJ
Goguel, AF
Bougaran, J
Ardouin, P
Court, BH
Perrin, JL
Vallancien, G
Triebel, F
Escudier, B
Citation: E. Angevin et al., Human renal cell carcinoma xenografts in SCID mice: Tumorigenicity correlates with a poor clinical prognosis, LAB INV, 79(7), 1999, pp. 879-888
Authors:
Zitvogel, L
Fernandez, N
Lozier, A
Wolfers, J
Merad, M
Angevin, E
Amigorena, S
Escudier, B
Citation: L. Zitvogel et al., Immunotherapy for cancer by dendritic cell therapy - From preclinical bases to therapeutic trial designs, EUROCANCER 98, 1998, pp. 289-291